201 related articles for article (PubMed ID: 24782995)
1. Breastfeeding and antithyroid drugs: a view from within.
Karras S; Krassas GE
Eur Thyroid J; 2012 Apr; 1(1):30-3. PubMed ID: 24782995
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data.
Karras S; Tzotzas T; Kaltsas T; Krassas GE
Pediatr Endocrinol Rev; 2010 Sep; 8(1):25-33. PubMed ID: 21037541
[TBL] [Abstract][Full Text] [Related]
3. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
4. SIDE EFFECTS OF PTU AND MMI IN THE TREATMENT OF HYPERTHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Yu W; Wu N; Li L; Wang J; OuYang H; Shen H
Endocr Pract; 2020 Feb; 26(2):207-217. PubMed ID: 31652102
[No Abstract] [Full Text] [Related]
5. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
6. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
7. Teratogen update: Antithyroid medications.
Romeo AN; Običan SG
Birth Defects Res; 2020 Sep; 112(15):1150-1170. PubMed ID: 32738035
[TBL] [Abstract][Full Text] [Related]
8. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
[TBL] [Abstract][Full Text] [Related]
9. Toxicological considerations for antithyroid drugs in children.
Karras S; Tzotzas T; Krassas GE
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.
Homsanit M; Sriussadaporn S; Vannasaeng S; Peerapatdit T; Nitiyanant W; Vichayanrat A
Clin Endocrinol (Oxf); 2001 Mar; 54(3):385-90. PubMed ID: 11298092
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the timing to reduce the initial dose of antithyroid drugs in patients with Graves' disease.
Nagayama Y; Eishima K; Hirayu H; Yamashita S; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Morita S; Izumi M
Endocrinol Jpn; 1990 Dec; 37(6):769-75. PubMed ID: 1714371
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil.
Momotani N; Yamashita R; Makino F; Noh JY; Ishikawa N; Ito K
Clin Endocrinol (Oxf); 2000 Aug; 53(2):177-81. PubMed ID: 10931098
[TBL] [Abstract][Full Text] [Related]
14. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
15. Antithyroid drugs during breastfeeding.
Hudzik B; Zubelewicz-Szkodzinska B
Clin Endocrinol (Oxf); 2016 Dec; 85(6):827-830. PubMed ID: 27561657
[TBL] [Abstract][Full Text] [Related]
16. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
17. Antithyroid Drugs.
Abdi H; Amouzegar A; Azizi F
Iran J Pharm Res; 2019; 18(Suppl1):1-12. PubMed ID: 32802086
[TBL] [Abstract][Full Text] [Related]
18. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
Morales DR; Fonkwen L; Nordeng HME
Br J Clin Pharmacol; 2021 Oct; 87(10):3890-3900. PubMed ID: 33783857
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
20. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]